E-Medicine's Perfect Storm
A look, in numbers, at the forces shaping electronic medicine.
Contributors
Antonio Regalado
Follow @twitterapiSenior Editor, Business
I am the business editor of MIT Technology Review. I look for stories about how technology is changing business. Before joining MIT Technology Review in July 2011, I lived in São Paulo, Brazil, where I wrote about science, technology, and politics in Latin America for Science and other publications. From 2000 to 2009, I was the science reporter at the Wall Street Journal and later a foreign correspondent.
Antonio Regalado's Stories
Two Patients Undergo Stem-Cell Blindness Treatment
A small biotech firm is the second company to start human tests of embryonic stem-cell therapy.
Stem-Cell Gamble
After years of controversy, a therapy based on human embryonic stem cells is finally being tested in humans. The treatment holds out hope to paralyzed people, but at how great a risk?
Khosla Biofuel IPO Draws Doubters
As yet another biofuels company prepares for a stock offering, some wonder if the company is worthy of going public at all.
How Mobile Phones Jump-Start Developing Economies
Ubiquitous handsets introduce mobile payments to those who lack bank accounts.
Building a Better Goat
Brazil's investment in transgenic animals shows how opposition to such technologies in the United States is opening opportunities elsewhere.
Guerrilla Webfare
How unauthorized video producers are "brand-jacking" companies and forcing them to rethink the way they market.
Searching for Biofuels' Sweet Spot
California-based Amyris has used breakthroughs in synthetic biology to reinvent biofuels. To turn its technology into an industrial process, it has headed to the land of sugar: Brazil.
The Lithium Rush
In the Bolivian Andes lies a vast salt flat that may shape the future of transportation.
